Contact US

NeoMed Unveils NeoConnect at Home OTC Reusable ENFit Syringe Line in the U.S.

NeoMed is excited to unveil NeoConnect® at Home™, a reusable port­folio of ENFit syringes that do not require a physician’s prescrip­tion. As a leading ENFit solu­tion provider, NeoMed is dedi­cated to making it easier than ever for home patients to access the ENFit syringes they need.

The NeoConnect® at Home™ line of ENFit syringes is the first of its kind to be avail­able over the counter (OTC) AND FDA 510(k) cleared for reuse. Ideal for patients in non-clinical and home­care settings, each syringe may be hand washed and reused up to 20 times by one user when cleaned per the cleaning instruc­tions provided with the syringe. Reusability allows for a cost-effective and eco-friendly alter­na­tive to single use ENFit syringes.

The syringe port­folio will be avail­able in four conve­nient sizes (3 mL, 6 mL, 12 mL and 60 mL). Complete with a durable polypropy­lene plunger and sili­cone O-ring gasket, the syringes will feature clear barrels with easy-to-read black mark­ings and will be offered in consumer-friendly case quan­ti­ties. The product line will be avail­able for purchase through retail and online stores, DME’s and home­care compa­nies in the fall of 2019.

ENFit is the regis­tered trade­mark of the Global Enteral Device Supplier Association (GEDSA) and is commonly used to iden­tify ISO 80369-3 compliant connec­tors. ENFit connec­tors help reduce the risk of enteral tube feeding miscon­nec­tions and improve patient safety. GEDSA encour­ages manu­fac­turers to intro­duce enteral devices with ENFit connec­tors, and health­care facil­i­ties to adopt feeding systems with ENFit connec­tors as soon as possible.

“The devel­op­ment of our NeoConnect® at Home™ line of OTC reusable ENFit syringes is a direct result of feed­back from customers concerned about ENFit syringe access and avail­ability. Not only have we made our syringes more acces­sible, we’ve added value by ensuring they can be reused. It is our hope that ENFit syringe OTC avail­ability and reusability will make enteral feeding and medica­tion delivery hassle-free and cost-effective,” said Marc Waldman, Vice President of Business Development at NeoMed.

“We are proud to be the first in the industry to offer reusable ENFit syringes that are avail­able without a prescrip­tion. We believe that this inno­va­tion will improve ENFit device access and advance the world­wide adop­tion and imple­men­ta­tion of safer enteral connec­tors,” remarked NeoMed President Aaron Ingram.

About NeoMed, Inc.

Founded in 2007, NeoMed develops inno­v­a­tive enteral collec­tion and delivery prod­ucts supporting the special­ized feeding and medica­tion dosing needs of the low birth weight, neonatal, and pedi­atric patients. With over 370 successful ENFit tran­si­tions repre­senting over 43 million admin­is­tered feed and medica­tion doses, NeoMed is committed to improve patient outcomes through product designs that meet safety, clin­ical, and regu­la­tory guide­lines while supporting cost-containment objec­tives.